ciclosporine

DRUG2 trials

Sponsors

Hospices Civils de Lyon, Nantes University Hospital

Conditions

Graft Versus Host DiseaseKidney TransplantationSkin Cancer

Phase 2

Study of First Line Treatment of Chronic Graft Versus Host Disease With the Association of Ciclosporine, Corticosteroids and Rituximab (Protocol R-GVHD)

CompletedNCT01135641

Nantes University HospitalGraft Versus Host Disease

Start: 2010-06-01End: 2014-03-01Updated: 2026-09-14

Phase 3

TUMORAPA 1: Efficacy of Rapamycin in Secondary Prevention of Skin Cancers in Kidney Transplant Recipients

CompletedNCT00133887

Hospices Civils de LyonKidney Transplantation, Skin Cancer

Start: 2004-04-30End: 2014-05-31Updated: 2025-12-26

Related Papers

Rituximab-based first-line treatment of cGVHD after allogeneic SCT: results of a phase 2 study

Blood2017-09-0138 citations

Sirolimus and secondary skin-cancer prevention in kidney transplantation.

2012-07-01363 citations